ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma
Authors
Keywords
-
Journal
Translational Oncology
Volume 21, Issue -, Pages 101441
Publisher
Elsevier BV
Online
2022-05-03
DOI
10.1016/j.tranon.2022.101441
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ALYREF Drives Cancer Cell Proliferation Through an ALYREF-MYC Positive Feedback Loop in Glioblastoma
- (2021) Jianjun Wang et al. OncoTargets and Therapy
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
- (2021) Zsuzsanna Nagy et al. Nature Communications
- The role of the HIF‐1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer
- (2021) Jing‐Zi Wang et al. Cancer Communications
- Identification and integrative analysis of ACLY and related gene panels associated with immune microenvironment reveal prognostic significance in hepatocellular carcinoma
- (2021) Yunfeng Xu et al. Cancer Cell International
- Multi-Omic Analyses of the m5C Regulator ALYREF Reveal Its Essential Roles in Hepatocellular Carcinoma
- (2021) Chen Xue et al. Frontiers in Oncology
- Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma
- (2020) Wenbiao Chen et al. Journal of Immunology Research
- Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
- (2020) Yun Hua Lee et al. Frontiers in Immunology
- Immunotherapy for Hepatocellular Carcinoma: A 2021 Update
- (2020) Christo Kole et al. Cancers
- Evaluating Distribution and Prognostic Value of New Tumor-Infiltrating Lymphocytes in HCC Based on a scRNA-Seq Study With CIBERSORTx
- (2020) Lixing Li et al. Frontiers in Medicine
- Tumor-infiltrating lymphocytes: Warriors fight against tumors powerfully
- (2020) Baisheng Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- Clinical significance and immunogenomic landscape analyses of the immune cell signature based prognostic model for patients with breast cancer
- (2020) Shiyuan Wang et al. BRIEFINGS IN BIOINFORMATICS
- ALYREF links 3′‐end processing to nuclear export of non‐polyadenylated mRNAs
- (2019) Jing Fan et al. EMBO JOURNAL
- Adjuvant Treatment of Hepatocellular Carcinoma: Prospect of Immunotherapy
- (2019) Zachary J. Brown et al. HEPATOLOGY
- Dual PD ‐1 and VEGFR ‐2 blockade promotes vascular normalization and enhances anti‐tumor immune responses in HCC
- (2019) Kohei Shigeta et al. HEPATOLOGY
- From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
- (2019) Yaojie Fu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A gene expression-based study on immune cell subtypes and glioma prognosis
- (2019) Qiu-Yue Zhong et al. BMC CANCER
- Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma
- (2018) Nataliya Rohr-Udilova et al. Scientific Reports
- OX40 expression in hepatocellular carcinoma is associated with a distinct immune microenvironment, specific mutation signature, and poor prognosis
- (2018) Kunlin Xie et al. OncoImmunology
- The NORAD lncRNA assembles a topoisomerase complex critical for genome stability
- (2018) Mathias Munschauer et al. NATURE
- Development and validation of an immune gene-set based Prognostic signature in ovarian cancer
- (2018) Sipeng Shen et al. EBioMedicine
- Impact of Tumor Purity on Immune Gene Expression and Clustering Analyses across Multiple Cancer Types
- (2017) Je-Keun Rhee et al. Cancer Immunology Research
- Immunology in the liver — from homeostasis to disease
- (2016) Felix Heymann et al. Nature Reviews Gastroenterology & Hepatology
- DNA Replication Stress as a Hallmark of Cancer
- (2015) Morgane Macheret et al. Annual Review of Pathology-Mechanisms of Disease
- Immunological landscape and immunotherapy of hepatocellular carcinoma
- (2015) Jesús Prieto et al. Nature Reviews Gastroenterology & Hepatology
- B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence
- (2012) Tai-Wei Sun et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- ALY as a potential contributor to metastasis in human oral squamous cell carcinoma
- (2012) Yasuhiro Saito et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Cell-cycle control in the face of damage – a matter of life or death
- (2009) Paul R. Clarke et al. TRENDS IN CELL BIOLOGY
- How To Build and Interpret a Nomogram for Cancer Prognosis
- (2008) Alexia Iasonos et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More